PROK2 and heart failure: Previous studies have revealed that PK2 and PKR1 levels are reduced in the late stage of heart failure, but PKR1 overexpression can protect cardiomyocytes from hypoxia injury-elicited apoptosis (Urayama et al., 2007; Gasser et al., 2015).